English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

LABELING was carried out by direct iodination of tizanidine (100 µg) with radioiodine (125I) in a fast single step at room temperature, to produce 125I-tizanidine (125I-TZN). 50 µg chloramine-T (CAT) was used as an oxidizing agent to oxidize the iodide ion to the iodonium ion, at neutral pH = 7 within 15 min. A high radiochemical yield of 92.8 % ± 0.1 was obtained. 125I-TZN was stable for 2 h without detection of any by-products in the reaction mixture. The partition coefficient value of 125I-TZN was 2.21 ± 0.02, showing that it is very lipophilic and can easily cross the blood brain barrier. Biodistribution studies and in vivo imaging showed that the initial brain uptake correlated fairly well with the brain-binding affinity of the compound. The brain uptake of 125I-TZN was as high as 5.2 % and 8.0 % in biodistribution studies and in vivo imaging at 120 min post injection, respectively. Thus, 125I-TZN is promising in radioreceptor assays for brain imaging.

Radioiodination and Biological Evaluation of Tizanidine as a Potential Brain Imaging Agent